QUEST DIAGNOSTICS INC (DGX) has 12 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $2.8M. Most recent filing: Sept. 3, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 3, 2026 filed Sept. 1, 2026 | Davis J. E. CEO and President | −$2,427,200 | 10,000 | −8% | Yes | |
|
|
||||||
| Aug. 31, 2026 filed Aug. 28, 2026 | PREVOZNIK MICHAEL E SVP & General Counsel | $2,969,404 | 69,031 | −100% | Yes | |
|
|
||||||
| July 29, 2026 filed July 28, 2026 | DELANEY MARK E SVP & Chief Commercial Officer | −$376,288 | 1,600 | −13% | Yes | |
|
|
||||||
| July 27, 2026 filed July 22, 2026 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | $7,652 | 37 | +0% | No | |
|
|
||||||
| July 27, 2026 filed July 22, 2026 | CARTER ROBERT B Director | $2,275 | 11 | +0% | No | |
|
|
||||||
Showing the 5 most recent of 12 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free